Literature DB >> 22648276

Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy.

Jingyuan Li1, Soban Umar, Andrea Iorga, Ji-Youn Youn, Yibin Wang, Vera Regitz-Zagrosek, Hua Cai, Mansoureh Eghbali.   

Abstract

Although the murine late pregnant (LP) heart is speculated to be a better functioning heart during physiological conditions, the susceptibility of LP hearts to I/R injury is still unknown. The aims of this study were to investigate the cardiac vulnerability of LP rodents to ischemia/reperfusion (I/R) injury and to explore its underlying mechanisms. In vivo female rat hearts [non-pregnant (NP) or LP] or ex vivo Langendorff-perfused mouse hearts were subjected to I/R. The infarct size was approximately fourfold larger in LP animals compared with NP both in vivo and ex vivo. The heart functional recovery was extremely poor in LP mice compared with NP (~10% recovery in LP vs. 80% recovery in NP at the end of reperfusion, P < 0.01). Interestingly, the poor functional recovery and the larger infarct size in LP were partially restored one day post-partum and almost fully restored 1 week post-partum to their corresponding NP levels. Mitochondrial respiratory function and the threshold for opening of the mitochondrial permeability transition pore were significantly lower in LP compared with NP when they both were subjected to myocardial I/R injury [Respiratory control ratio = 1.9 ± 0.1 vs. 4.0 ± 0.5 in NP, P < 0.05; calcium retention capacity (CRC) = 167 ± 10 vs. 233 ± 18 nmol/mg protein in NP, P < 0.01]. Cardiac reactive oxygen species (ROS) generation, as well mitochondrial superoxide production, was approximately twofold higher in LP compared with NP following I/R. The phosphorylation levels of Akt, ERK1/2, and STAT3, but not GSK3β, were significantly reduced in the hearts from LP subjected to I/R. In conclusion, increased mitochondrial ROS generation, decreased CRC as well as impaired activation of Akt/ERK/STAT3 at reperfusion are the possible underlying mechanisms for higher vulnerability of LP hearts to I/R.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648276      PMCID: PMC3769136          DOI: 10.1007/s00395-012-0271-7

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  72 in total

Review 1.  Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?

Authors:  Sandrine Lecour
Journal:  J Mol Cell Cardiol       Date:  2009-01-20       Impact factor: 5.000

2.  Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection.

Authors:  Gerd Heusch; Kerstin Boengler; Rainer Schulz
Journal:  Basic Res Cardiol       Date:  2010-03       Impact factor: 17.165

3.  A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.

Authors:  Jean Chrisostome Bopassa; Mansoureh Eghbali; Ligia Toro; Enrico Stefani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-30       Impact factor: 4.733

4.  Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes.

Authors:  Dennis Rottlaender; Kerstin Boengler; Martin Wolny; Guido Michels; Jeannette Endres-Becker; Lukas J Motloch; Astrid Schwaiger; Astrid Buechert; Rainer Schulz; Gerd Heusch; Uta C Hoppe
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

5.  Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.

Authors:  Lydia Lacerda; Sarin Somers; Lionel H Opie; Sandrine Lecour
Journal:  Cardiovasc Res       Date:  2009-08-07       Impact factor: 10.787

6.  Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism.

Authors:  Jun Zhang; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2010-01-12       Impact factor: 5.000

7.  Estrogen contributes to gender differences in mouse ventricular repolarization.

Authors:  Tomoaki Saito; Andrea Ciobotaru; Jean Chrisostome Bopassa; Ligia Toro; Enrico Stefani; Mansoureh Eghbali
Journal:  Circ Res       Date:  2009-07-16       Impact factor: 17.367

8.  Myocardial reperfusion injury management: erythropoietin compared with postconditioning.

Authors:  Sophie Tamareille; Nehmat Ghaboura; Frederic Treguer; Dalia Khachman; Anne Croué; Daniel Henrion; Alain Furber; Fabrice Prunier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

9.  Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.

Authors:  Marek Kuch; Maciej Janiszewski; Artur Mamcarz; Agnieszka Cudnoch-Jedrzejewska; Mirosław Dłuzniewski
Journal:  Med Sci Monit       Date:  2009-06

Review 10.  The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.

Authors:  Derek J Hausenloy; Sang-Bing Ong; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2009-02-26       Impact factor: 17.165

View more
  14 in total

1.  The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two.

Authors:  Jingyuan Li; Xuqi Chen; Rebecca McClusky; Maureen Ruiz-Sundstrom; Yuichiro Itoh; Soban Umar; Arthur P Arnold; Mansoureh Eghbali
Journal:  Cardiovasc Res       Date:  2014-03-19       Impact factor: 10.787

Review 2.  Pregnancy as a cardiac stress model.

Authors:  Eunhee Chung; Leslie A Leinwand
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

Review 3.  Maternal cardiac metabolism in pregnancy.

Authors:  Laura X Liu; Zolt Arany
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

4.  Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway.

Authors:  Jingyuan Li; Gregoire Ruffenach; Georgios Kararigas; Christine M Cunningham; Negar Motayagheni; Neusha Barakai; Soban Umar; Vera Regitz-Zagrosek; Mansoureh Eghbali
Journal:  J Mol Cell Cardiol       Date:  2016-11-12       Impact factor: 5.000

5.  NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish.

Authors:  Yixuan Zhang; Hirohito Shimizu; Kin Lung Siu; Aman Mahajan; Jau-Nian Chen; Hua Cai
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

6.  Renal redox response to normal pregnancy in the rat.

Authors:  Mark W Cunningham; Jennifer M Sasser; Crystal A West; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-01-02       Impact factor: 3.619

7.  Pregnancy-induced physiological hypertrophy protects against cardiac ischemia-reperfusion injury.

Authors:  Junjie Xiao; Jin Li; Tianzao Xu; Dongcao Lv; Bo Shen; Yang Song; Jiahong Xu
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 8.  Metabolic Coordination of Physiological and Pathological Cardiac Remodeling.

Authors:  Andrew A Gibb; Bradford G Hill
Journal:  Circ Res       Date:  2018-06-22       Impact factor: 17.367

Review 9.  Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

Review 10.  Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues.

Authors:  Fouad A Zouein; Raffaele Altara; Qun Chen; Edward J Lesnefsky; Mazen Kurdi; George W Booz
Journal:  Front Cardiovasc Med       Date:  2015-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.